Find your path to Paul
831 people in our graph share verified history with Paul — schools, employers, funds. One of them is your warm intro.
Angela ToyunlockedPaul: together at HSBC (2010–2012)
×3Paul: together at HSBC
×5Paul: together at University of Bath
Paul: together at Standard Chartered Bank
About
Paul Denslow is the CEO and Co-Founder of Intus Bio, a microbiome company that developed the GutID test and the Titan-1 platform, which combines next-generation sequencing with AI-powered analysis. He also serves as Board Chair at Intus Bio, where the company works with institutions to develop microbiome-based tools for the diagnosis, early detection, and prevention of cancer and other chronic diseases.
CEO & Co-Founder at Intus Biosciences
Intro paths
→
In turn, Paul can intro founders to Intus Biosciences's investors below.
Intus Biosciences's investors · 1
Co-founders at Intus Biosciences
TP
Thomas P JarvieExecutive Officer, Director
MD
Mark DriscollCSO & Co-Founder
Experience
- Intus BioBoard Chaircurrent2022 — present
- Intus BioCEO & Co-Foundercurrent2021 — present
- Intus BioBoard Member2021 — 2022
- Canford PartnersFoundercurrent2018 — present
- Modulo BioAdvisorcurrent2021 — present
- CytoVerisAdvisorcurrent2020 — present
- QuidientAdvisorcurrent2019 — present
- Standard Chartered BankManaging Director - Head of FX, Americas2014 — 2018New York City Metropolitan Area
- HSBCSenior Vice President, FX Sales2003 — 2014
- HSBCInternational Graduate Trainee, Investment Banking and Markets2001 — 2003
- HSBCAnalyst Equity, Capital Markets2000Greater London, England, United Kingdom
- KPMG UKAnalyst, Forensic Accounting1999 — 2000Greater London, England, United Kingdom
Skills & more
Derivatives10Capital Markets10Fixed Income13Hedge Funds7Investment Banking5FX Options7Financial Markets4Equities3
- Series 63 — FINRA
- Series 7 — FINRA
- Series 24 — FINRA
From Paul's professional profile.
Frequently asked questions
- Who is Paul Denslow?
- Paul Denslow is the CEO and Co-Founder of Intus Bio, a microbiome company that developed the GutID test and the Titan-1 platform, which combines next-generation sequencing with AI-powered analysis. He also serves as Board Chair at Intus Bio, where the company works with institutions to develop microbiome-based tools for the diagnosis, early detection, and prevention of cancer and other chronic diseases.
- Where does Paul Denslow work?
- Paul Denslow is CEO & Co-Founder at Intus Biosciences.
- Where did Paul Denslow go to school?
- Paul Denslow studied at University of Bath (Bachelor of Science - BS, Economics).
Same school
Also attended University of Bath223
Catherine BergersenSenior Executive Assistant at Mayfair Equity PartnersJohanInvestor at InvestinorMaddie CoughlinInvestor at DN CapitalBen PalmerInvestment Professional at OxxJuliette PetitChief of Staff at Keen Venture PartnersSarah HollyheadDirector at Marlin Equity Partners
+ 217 more
Shared employers
Also worked at Intus Bio2
Also worked at CytoVeris1
Also worked at Standard Chartered Bank192
Hussain AbdullaFounding Partner, MENA at Golden Gate VenturesPhil VenablesVenture Partner at Ballistic VenturesYasser MestarihiHead of Middle East at Type One VenturesOmesh FabianiCo-Head of Private Credit, Onyx at Openspace VenturesNichapat ArkDirector, Head of Thailand at Openspace VenturesAnthony AvedissianPartner at Canonical Crypto
+ 186 more
